Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
Go back to Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors| (NASDAQ: ATRA) | Delayed: 10.23 +0.47 (4.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.76 | 52 Week High | $40.80 | |||
| Open | $10.60 | 52 Week Low | $12.45 | |||
| Day High | $11.33 | P/E | N/A | |||
| Day Low | $10.23 | EPS | $0.00 | |||
| Volume | 106,673 | |||||

